Spastic paraparesis

Search Trials
Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Status:
Unknown status
Last Changed:
Jul 22, 2011
First Changed:
Apr 28, 2011
Disease(s):
HTLV-I-Associated Myelopathy
Intervention(s):
Tamibarotene
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Status:
Completed
Last Changed:
Jan 29, 2019
First Changed:
Feb 4, 2004
Disease(s):
HTLV-1
Intervention(s):
Hu MiK-Beta-1
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Last Changed:
Jun 3, 2016
First Changed:
May 14, 2008
Disease(s):
Amyotrophic Lateral Sclerosis
Intervention(s):
No intervention
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Status:
Completed
Last Changed:
Mar 4, 2008
First Changed:
Aug 23, 2001
Disease(s):
Primary Lateral Sclerosis

Connect. Empower. Inspire.